Gain Therapeutics Inc (GANX NASDAQ) stock market data APIs
$1.7453
-0.1(-5.7%)
as of May 21, 2026
Try our APIs with
free plan!
Gain Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia. The company's drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. Its lead drug candidate is GT-02287, which is currently in a Phase 1b study for the treatment of Parkinson's disease with or without a GBA1 mutation. The company has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of dementia with Lewy bodies, Alzheimer's disease, and Gaucher's disease, lysosomal storage disorders, metabolic disorders, and solid tumors. Gain Therapeutics, Inc. was founded in 2017 and is based in Bethesda, Maryland.
Prev. Close
1.7453
Open
1.6404
High
1.754
Low
1.6164
52 wk Range
1.41-4.34
Market Cap
70 379 K
Shares Outstanding
42 654 K
EPS
-0.1328
Beta
0.154
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Gain Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Gain Therapeutics Inc data using free add-ons & libraries
Get Gain Therapeutics Inc Fundamental Data
Gain Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -19 669 370
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-19
- EPS/Forecast: -0.1575
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Gain Therapeutics Inc News
New
Gain Therapeutics (GANX) Shares Edge Higher After Narrower-Than-Expected Q1 Loss
medical research 10 ©Pixnio Gain Therapeutics, Inc. (NASDAQ:GANX) shares rose 3.4% in premarket trading on Monday after the biotechnology company reported first-quarter results that came in ahead of...
Wednesday Sector Laggards: Precious Metals, Biotechnology Stocks
In trading on Wednesday, precious metals shares were relative laggards, down on the day by about 2.9%. Helping drag down the group were shares of Avino Silver & Gold Mines, off about 8% and shares of...
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
BETHESDA, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and developme...
Gain Therapeutics to Attend the 2025 Maxim Growth Summit
BETHESDA, Md., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and developme...
Get Gain Therapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
